Replies to post #199077 on Elite Pharmaceuticals Inc (ELTP)

[Gman24]

Can you name the next two ADF's that Nasrat is planning on submitting by the end of this year ?... SequestOx is coming. Only two short months away.

[rollin2nyte]

Do you have a link that proves that millions upon millions have been dumped?

[Couch]

Whats the difference, that wasnt the question.

The point in question was whether millions upon millions of shares were being dumped into the market.

Answer: YES!!

Speculation as to how the proceeds of sale were being deployed by the seller is another question. Any proof to your claim of how it was used???

Link??

Didnt think so

I love debunking the BS that gets bandied about in regards to the company.

As of November 5, 2015, the issuer had outstanding 684,756,279 shares of common stock, $0.001 par value (exclusive of 100,000 shares held in treasury).

As of February 4, 2016, the issuer had outstanding 695,168,934 shares of common stock, $0.001 par value (exclusive of 100,000 shares held in treasury).

NOW in terms of where the money was spent. It's called R&D costs. And here is what Elite spent last quarter.

Consolidated revenues for the third quarter of Fiscal 2016 were $2.2 million, a 61% increase on a year-on-year basis. The increase in revenues is due to the continued growth of Elite's niche generic product lines. During the quarter, Elite invested an additional $3.2 million in the development of SequestOx™ (ELI-200), immediate release Oxycodone with sequestered Naltrexone, the first product in Elite's line of abuse-deterrent opioids.

SO what we have is the increase in shares ALL went to R&D costs.

GLAD I CAN CLEAR UP THE BS